共 8 条
[5]
Racial Disparities in Tissue Plasminogen Activator Treatment Rate for Stroke: A Population-Based Study[J] . Amie W. Hsia,Dorothy F. Edwards,Lewis B. Morgenstern,Jeffrey J. Wing,Nina C. Brown,Regina Coles,Sarah Loftin,Andrea Wein,Sara S. Koslosky,Sabiha Fatima,Brisa N. Sánchez,Ali Fokar,M. Chris Gibbons,Nawar Shara,Annapurni Jayam-Trouth,Chelsea S. Kidwell.Stroke . 2011 (8)
[6]
Using Recombinant Tissue Plasminogen Activator to Treat Acute Ischemic Stroke in China: Analysis of the Results From the Chinese National Stroke Registry (CNSR)[J] . Yilong Wang,Xiaoling Liao,Xingquan Zhao,David Z. Wang,Chunxue Wang,Mai N. Nguyen-Huynh,Yong Zhou,Liping Liu,Xianwei Wang,Gaifen Liu,Hao Li,Yongjun Wang.Stroke . 2011 (6)
[8]
Stroke in China: epidemiology, prevention, and management strategies[J] . Ming Liu,Bo Wu,Wen-Zhi Wang,Li-Ming Lee,Shi-Hong Zhang,Ling-Zhi Kong.Lancet Neurology . 2007 (5)